Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today reports financial results for the fourth quarter and full year ended December 31, 2025. Owlet’s...
Award-Winning Agency to Lead Strategic Communication as Owlet Expands Its Mission to Bring More Wellness Insights and Better Starts to Families Worldwide
Owlet , Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, plans to announce fourth quarter and full year 2025 financial results after market close on...
The partnership expands Owlet’s pediatric DME distribution footprint and supports extended commercial activation
Strategic investment in private AI infrastructure positions Owlet to compound value from its growing base of proprietary infant wellness data
Report draws on Owlet’s massive infant sleep dataset, one of the world’s largest, to reveal how babies sleep – evaluating bedtimes, wake-ups, sleep stretches, and biometric trends
Collaboration expands Owlet’s national DME footprint, strengthens access for Medicaid and TRICARE families, and supports continued growth in prescription-backed revenue channel.
A new subscription service for Owlet users turns baby health and sleep trends into clear, personalized guidance, while core health tracking and notification features remain free.
Owlet Babet Care (OWLT) has strong technical momentum and is trading at a new 3-year high. Shares are up 200% over the past year. OWLT maintains a 100% “Buy” opinion from Barchart. Wall Street rates...
TGA approval enables regional launch of Owlet’s clinically validated, award-winning infant health monitor; Owlet360™ subscription marks first international expansion of the Company’s recurring-revenue...